Ellie Phylactopoulos

Ellie Phylactopoulos has a diverse work experience spanning multiple industries. Ellie began their career as a Business Analyst Intern at Lifescience Dynamics Limited in January 2021 and continued in a similar role until July 2022. From August 2022, they were promoted to the position of Senior Business Analyst at the same company.

Prior to their role at Lifescience Dynamics Limited, Ellie worked as a Postdoctoral Researcher at UCL from October 2019 to November 2020. Their research focused on investigating the potential impact of mTORi on lung regenerative capacity in Idiopathic Pulmonary Fibrosis. Ellie was responsible for designing and managing scientific experiments, analyzing data, collaborating with fellow researchers, and training junior lab members.

Before their postdoctoral research position, Ellie served as a PHD Candidate at The Francis Crick Institute from July 2017 to October 2019. During this time, they worked on the development of an innovative therapy for oesophageal atresia, particularly in the identification of a novel stem cell population and the reconstruction of a tissue engineered oesophagus. Ellie also analyzed complex data sets as part of their research.

Overall, Ellie Phylactopoulos has a strong background in business analysis, scientific research, experimental design, data analysis, and collaboration in the medical and scientific fields.

Ellie Phylactopoulos completed their education history as follows. From 2015 to 2019, they attended UCL where they pursued a Doctor of Philosophy (PhD) degree in the field of Stem Cells & Regenerative Medicine. Prior to that, they studied at Imperial College London from 2014 to 2015, where they earned a Master of Science (MS) degree in Molecular Medicine. Their undergraduate education took place at the University of York from 2011 to 2014, where they obtained a Bachelor of Science (BS) degree in Biology, General.